Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Lilly to invest $1B in new plant in North Carolina

By Brian Buntz | January 28, 2022

Eli LillyEli Lilly and Co. (NYSE:LLY) said it would invest more than $1 billion to build a new manufacturing facility in Concord, North Carolina.

The company says it would hire almost 600 new employees to staff the new site, which will include a campus of five buildings focused on manufacturing parenteral (injectable) products and devices.

The average salary for the new employees will be approximately $70,000.

The location of the proposed 800,000-ft2 site was formerly occupied by a Philip Morris plant.

“Expanding our manufacturing footprint in North Carolina enables us to continue to produce today’s medicines while providing additional capacity to manufacture the medicines of tomorrow,” said Edgardo Hernandez, senior vice president and president, Lilly Manufacturing Operations, in a statement. “We are pleased to again partner with North Carolina to bring jobs to American workers and provide more medicines that patients need to address health challenges.”

Lilly said it chose to invest in the Concord area, near Charlotte, because of the city’s manufacturing prowess, transportation infrastructure and proximity to universities.

In 2020, Lilly announced an investment in North Carolina’s Research Triangle Park in Durham.

Lilly noted that the planned investment in Concord is predicated on receiving county and municipal government permits and other approvals.

The company would receive some $17 million in state tax rebates for the facility and local incentives valued at approximately $75 million.

Lilly also announced plans to invest more than €400 million in a new manufacturing plant in Limerick, Ireland that would lead to the creation of more than 300 jobs.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE